Young Diane, Bilello Seth, Gomelsky Alex
Department of Urology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130, USA.
South Med J. 2007 May;100(5):537-9. doi: 10.1097/SMJ.0b013e31802f1e17.
There have been less than 100 reported cases of carcinoma in a female urethral diverticulum, with only 10 of these cases being squamous cell carcinoma (SCC). The course of this disease is frequently aggressive, despite multimodality treatment, and most patients die within 2 to 3 years. To our knowledge, carcinoma in situ of the female urethral diverticulum has not been reported to date, and thus, optimal treatment is not well defined. A 41-year-old woman was found to have SCC in situ without evidence of invasive carcinoma after diverticulectomy. She elected close observation and remains disease-free at 2 years. A brief overview is given of the presentation, management, and outcomes of urethral diverticular carcinoma.
据报道,女性尿道憩室癌病例不足100例,其中仅10例为鳞状细胞癌(SCC)。尽管采用了多模式治疗,但这种疾病的病程通常进展迅速,大多数患者在2至3年内死亡。据我们所知,迄今为止尚未报道过女性尿道憩室原位癌,因此,最佳治疗方法尚未明确界定。一名41岁女性在憩室切除术后被发现患有原位鳞状细胞癌,无浸润性癌证据。她选择密切观察,2年后仍无疾病复发。本文简要概述了尿道憩室癌的临床表现、治疗及预后。